Deciphera Pharmaceuticals Inc (DCPH) - News Archive

In a significant development within the oncology pharmaceutical sector, Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), has announced that the results from its MOTION pivotal Phase 3 study of vimseltinib in patients wit...

WALTHAM, Mass. - Deciphera Pharmaceuticals, a renowned biopharmaceutical company dedicated to the development of groundbreaking cancer treatments, has recently announced the release of long-term findings from the INTRIG...

In a significant development, GENESIS Pharma, a renowned regional biopharmaceutical company operating in Europe, has recently entered into an exclusive distribution agreement with Deciphera Pharmaceuticals, Inc. The agr...

Massachusetts-based biopharmaceutical company, Deciphera Pharmaceuticals, recently unveiled its strategic outlook for 2024 and disclosed preliminary unaudited fourth quarter and full year 2023 revenue figures. These ann...

Deciphera Pharmaceuticals, a formidable player in the biopharmaceutical domain, continues to leave an indelible impact in the global fight against cancer. It recently announced a significant accomplishment - Nature Medi...